Response to Sorscher
J Natl Cancer Inst
.
2024 Jan 10;116(1):174.
doi: 10.1093/jnci/djad234.
Authors
Félix Balazard
1
,
Aurélie Bertaut
2
,
Ines Vaz-Luis
3
,
Barbara Pistilli
3
4
5
Affiliations
1
Owkin Inc, New York, USA.
2
Centre George François Leclerc, Dijon, France.
3
Department of Medical Oncology, Gustave Roussy, Villejuif, France.
4
Department of Supportive Care and Pathways (DIOPP) Oncology, Gustave Roussy, Villejuif, France.
5
INSERM 981, Gustave Roussy, Villejuif, France.
PMID:
37952229
DOI:
10.1093/jnci/djad234
No abstract available
Publication types
Comment